These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21417616)

  • 21. In vitro adsorption of plasma proteins onto the surface (charges) modified-submicron emulsions for intravenous administration.
    Tamilvanan S; Schmidt S; Müller RH; Benita S
    Eur J Pharm Biopharm; 2005 Jan; 59(1):1-7. PubMed ID: 15567295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of citral in emulsions coated with cationic biopolymer layers.
    Yang X; Tian H; Ho CT; Huang Q
    J Agric Food Chem; 2012 Jan; 60(1):402-9. PubMed ID: 22148257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of casein-phospholipid combinations as emulsifier on the physical and oxidative stability of fish oil-in-water emulsions.
    García-Moreno PJ; Frisenfeldt Horn A; Jacobsen C
    J Agric Food Chem; 2014 Feb; 62(5):1142-52. PubMed ID: 24437721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cationic surfactant on transport of surface-active and non-surface-active model drugs and emulsion stability in triphasic systems.
    Chidambaram N; Burgess DJ
    AAPS PharmSci; 2000; 2(3):E28. PubMed ID: 11741244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of iota-carrageenan on droplet flocculation of beta-lactoglobulin-stabilized oil-in-water emulsions during thermal processing.
    Gu YS; Decker EA; McClements DJ
    Langmuir; 2004 Oct; 20(22):9565-70. PubMed ID: 15491187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production and characterization of O/W emulsions containing cationic droplets stabilized by lecithin-chitosan membranes.
    Ogawa S; Decker EA; McClements DJ
    J Agric Food Chem; 2003 Apr; 51(9):2806-12. PubMed ID: 12696977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation parameters influencing the physicochemical characteristics of rosiglitazone-loaded cationic lipid emulsion.
    Davaa E; Park JS
    Arch Pharm Res; 2012 Jul; 35(7):1205-13. PubMed ID: 22864743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of in vitro efficacy of a novel schistosomicidal drug by incorporation into nanoemulsions.
    de Araújo SC; de Mattos AC; Teixeira HF; Coelho PM; Nelson DL; de Oliveira MC
    Int J Pharm; 2007 Jun; 337(1-2):307-15. PubMed ID: 17292573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pickering w/o emulsions: drug release and topical delivery.
    Frelichowska J; Bolzinger MA; Valour JP; Mouaziz H; Pelletier J; Chevalier Y
    Int J Pharm; 2009 Feb; 368(1-2):7-15. PubMed ID: 18992799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of surfactant structure on the phase inversion of emulsions stabilized by mixtures of silica nanoparticles and cationic surfactant.
    Cui ZG; Yang LL; Cui YZ; Binks BP
    Langmuir; 2010 Apr; 26(7):4717-24. PubMed ID: 19950938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of surface charge on the stability of oil/water emulsions during steam sterilization.
    Chansiri G; Lyons RT; Patel MV; Hem SL
    J Pharm Sci; 1999 Apr; 88(4):454-8. PubMed ID: 10187757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of environmental stresses on stability of oil-in-water emulsions containing droplets stabilized by beta-lactoglobulin-iota-carrageenan membranes.
    Gu YS; Regnier L; McClements DJ
    J Colloid Interface Sci; 2005 Jun; 286(2):551-8. PubMed ID: 15897070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved gene expression pattern using Epstein-Barr virus (EBV)-based plasmid and cationic emulsion.
    Min KA; Lee SK; Kim CK
    Biomaterials; 2005 Mar; 26(9):1063-70. PubMed ID: 15369695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physicochemical characterization and acute toxicity evaluation of a positively-charged submicron emulsion vehicle.
    Klang SH; Frucht-Pery J; Hoffman A; Benita S
    J Pharm Pharmacol; 1994 Dec; 46(12):986-93. PubMed ID: 7714723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
    Guinedi AS; Mortada ND; Mansour S; Hathout RM
    Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of bacterial surface properties to control the stability of emulsions.
    Ly MH; Naïtali-Bouchez M; Meylheuc T; Bellon-Fontaine MN; Le TM; Belin JM; Waché Y
    Int J Food Microbiol; 2006 Oct; 112(1):26-34. PubMed ID: 16952409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An oral delivery system for indomethicin engineered from cationic lipid emulsions and silica nanoparticles.
    Simovic S; Hui H; Song Y; Davey AK; Rades T; Prestidge CA
    J Control Release; 2010 May; 143(3):367-73. PubMed ID: 20079390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of stearylamine and dicetylphosphate on the physical properties of submicron O/W emulsions.
    Mbela N; Verschueren E; Ludwig A
    J Pharm Belg; 1998; 53(2):81-6. PubMed ID: 9609968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extensive surface studies help to analyse zeta potential data: the case of cationic emulsions.
    Rabinovich-Guilatt L; Couvreur P; Lambert G; Goldstein D; Benita S; Dubernet C
    Chem Phys Lipids; 2004 Aug; 131(1):1-13. PubMed ID: 15210360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery.
    Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
    J Drug Target; 2011 Jul; 19(6):409-17. PubMed ID: 20678034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.